Mestrelab develops scientific software from Santiago de Compostela, and its products are deployed globally. Its NMR spectra analysis software, Mnova, is widely used in R&D teams across the biotechnology sector, being recognized for its ability to elucidate new structures and identify molecules of pharmacological interest. Mnova is the number one solution globally having surpassed 260,000 highly specialized users in 2024, with license sales in a total of 118 countries.
Business areas:
- Academic: over 1,000 customers, including 91% of the world’s 100 most prestigious Universities.
- Biotech/Pharmaceutical: 64% of the 50 largest biotech and pharmaceutical companies (Genentech, Novartis, Roche, Pfizer, AstraZeneca, Merck Inc, Johnson and Johnson)
- Chemicals: 40% of the 20 largest chemical companies.
Business lines
- Software products for analytical data (NMR, mass spectrometry, and vibrational spectroscopy)
- Electronic laboratory notebook
- Automatic processing of analytical data
- Software development for specific applications through R&D&I projects with collaborators such as BASF, Syngenta, Novartis, Abbvie, Genentech, Johnson and Johnson, Merck KGaA, Bath University, Imperial College, American Chemical Society, etc.